Details for New Drug Application (NDA): 210048
✉ Email this page to a colleague
The generic ingredient in BACLOFEN is baclofen. There are twenty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the baclofen profile page.
Summary for 210048
Tradename: | BACLOFEN |
Applicant: | Maia Pharms Inc |
Ingredient: | baclofen |
Patents: | 0 |
Pharmacology for NDA: 210048
Mechanism of Action | GABA A Agonists GABA B Agonists |
Medical Subject Heading (MeSH) Categories for 210048
Suppliers and Packaging for NDA: 210048
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 210048 | ANDA | Sagent Pharmaceuticals | 25021-678 | 25021-678-20 | 1 VIAL in 1 CARTON (25021-678-20) / 20 mL in 1 VIAL |
BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 210048 | ANDA | Sagent Pharmaceuticals | 25021-679 | 25021-679-20 | 1 VIAL in 1 CARTON (25021-679-20) / 20 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRATHECAL | Strength | 0.5MG/ML | ||||
Approval Date: | Sep 11, 2019 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRATHECAL | Strength | 2MG/ML | ||||
Approval Date: | Sep 11, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription